Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Withholding versus maintaining aspirin before coronary artery bypass graft surgery
IRCT20141209020258N150Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin in coronary arteriosclerosis (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Bleeding, Mean number of postoperative FFP and 2 more. Started Dec 2018; status: completed.
02
Drugs
aspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20141209020258N150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N150.